Related Experiment Videos
[Controversies regarding the use of 0.75% bupivacaine]
P Knapik1, G Gallert, M Knapik
1Zakładu Anastezjologii i Intensywnej Terapii Górniczego Centrum Medycznego, Katowicach.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|July 1, 1992
Abstract:
Controversies are described regarding wide introduction of bupivacaine with raised concentration (0.75%) of the active components, which has been introduced in other countries in the strongest local anaesthetic agent used as yet but in early 1980s it has been withdrawn from several western countries in view of possible serious cardiovascular side effects. Presently, after a number of studies it been demonstrated that these suppositions were unfounded and the observed complication were due errors in anaesthesiological techniques and not to an exceptional cardiotoxicity of the drug.